92 related articles for article (PubMed ID: 32239101)
1. Prognostic significance of E-cadherin expression in hepatocellular carcinoma: correlations with clinical features.
Dobrescu AE; Basa SN; Cornianu M; Lazăr DC; Suciu SC; Tudor A; Viţa OC; Tarţă-Marcu DC; Barna RA; Lazăr OF
Rom J Morphol Embryol; 2019; 60(4):1243-1251. PubMed ID: 32239101
[TBL] [Abstract][Full Text] [Related]
2. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
[TBL] [Abstract][Full Text] [Related]
3. Altered distribution and expression pattern of E-cadherin in hepatocellular carcinomas: correlations with prognosis and clinical features.
Jiang XM; Zhang JB; Xiong J; Huang XX; Ren ZG
Asian Pac J Cancer Prev; 2012; 13(12):6455-61. PubMed ID: 23464474
[TBL] [Abstract][Full Text] [Related]
4. [Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].
Chen XJ; Wu LM; Xu XB; Feng XW; Xie HY; Zhang M; Shen Y; Wang WL; Liang TB; Zheng SS
Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1354-8. PubMed ID: 18241575
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis.
Chen J; Zhao J; Ma R; Lin H; Liang X; Cai X
PLoS One; 2014; 9(8):e103952. PubMed ID: 25093414
[TBL] [Abstract][Full Text] [Related]
6. Expression of P-aPKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma.
Du GS; Wang JM; Lu JX; Li Q; Ma CQ; Du JT; Zou SQ
Ann Surg Oncol; 2009 Jun; 16(6):1578-86. PubMed ID: 19290490
[TBL] [Abstract][Full Text] [Related]
7. Methylation of tumour suppressor genes
El-Bendary M; Nour D; Arafa M; Neamatallah M
Br J Biomed Sci; 2020 Jan; 77(1):35-40. PubMed ID: 31790342
[No Abstract] [Full Text] [Related]
8. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
9. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
10. Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment.
Inayoshi J; Ichida T; Sugitani S; Tsuboi Y; Genda T; Honma N; Asakura H
J Gastroenterol Hepatol; 2003 Jun; 18(6):673-7. PubMed ID: 12753149
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of E-cadherin, CD34 in the patients with hepatocellular carcinoma].
Wu LQ; Lu Y; Lu HJ; Zhang B; Yang JY; Ma X
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):774-7. PubMed ID: 16836930
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
Endo K; Ueda T; Ueyama J; Ohta T; Terada T
Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
[TBL] [Abstract][Full Text] [Related]
15. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
16. Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.
Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ren WH; Ge YS; Yu JH; Liu WB; Wang W
J Surg Res; 2012 May; 174(1):120-9. PubMed ID: 21316706
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion.
Yan X; Zhou H; Zhang T; Xu P; Zhang S; Huang W; Yang L; Gu X; Ni R; Zhang T
Tumour Biol; 2015 Dec; 36(12):9611-9. PubMed ID: 26142732
[TBL] [Abstract][Full Text] [Related]
18. Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Liu J; Ni W; Qu L; Cui X; Lin Z; Liu Q; Zhou H; Ni R
Dig Dis Sci; 2016 Sep; 61(9):2554-67. PubMed ID: 27221498
[TBL] [Abstract][Full Text] [Related]
19. Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis.
Yamada S; Nomoto S; Fujii T; Takeda S; Kanazumi N; Sugimoto H; Nakao A
Anticancer Res; 2007; 27(4B):2269-74. PubMed ID: 17695513
[TBL] [Abstract][Full Text] [Related]
20. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
